NCT07497958Not yet recruiting
Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy
Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy: a Randomized Controlled Clinical Study
Source: ClinicalTrials.gov · Last updated 27 Mar 2026
Brief summary (registry, in English)
It is demonstrated that remote ischemic preconditioning can alleviate the degree of acute renal injury on the operated side in patients undergoing partial nephrectomy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 174 (estimated)
- First submitted
- 15 Mar 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Kidney cancer
- NCT number
- NCT07497958
What you commit to
- Study type: Interventional
- Planned participants: 174
- From 1 Apr 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The anesthesiologist assesses that the patient cannot tolerate general anesthesia surgery
Other illness
- Individuals with severe cardiovascular and cerebrovascular diseases, uncontrolled hypertension, and diabetes
Lab values
- Estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73m²
Other
- Horseshoe kidney
- Solitary kidney
- Pregnant women
Who the study is looking for
- Patients who are scheduled to undergo partial nephrectomy, with no specific surgical procedure limitation, including laparoscopic surgery, robot-assisted surgery, and open surgery
- Aged 18 to 80
- Possess good organ function status: sufficient organ function (based on the normal values of the clinical trial center)
- Blood routine test: WBC≥3.5×10\^9/L, absolute neutrophil count ≥1.5×10\^9/L, PLT≥75.0×10\^9/L, HGB≥80g/L;
- Liver function: Total bilirubin ≤1.5×upper limit of normal (ULN), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤2.5×ULN;
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 651 Dongfeng Road East, Yuexiu District, Guangzhou, P.R. China Sun Yat-sen University Cancer Center； Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.